Santos da Silva Jorge, CEO of MoonLake Immunotherapeutics ($MLTX), made two open market stock sales in the last 365 days totaling $2.97 million. His most recent sale occurred on December 9, 2025. These sales rank 2,743rd among 11,678 insiders in our database, well below the average of $8.6 million across 6.4 transactions. No open market purchases were recorded.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | A | Stock Option (Right to Buy) | 520342 | $0.00 | 520,342.0000 | 64,037,478 | 9999.99% | 0.81% |
| Dec. 19, 2025 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | C | Common shares, par value CHF 0.10 per share, of MoonLake AG | 5836 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.01% |
| Dec. 19, 2025 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | D | Class C ordinary shares, par value $0.0001 per share | 196316 | $0.00 | 0.0000 | 64,037,478 | 100.00% | 0.31% |
| Dec. 19, 2025 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | C | Class A ordinary shares, par value $0.0001 per share | 196316 | $0.00 | 3,074,893.0000 | 64,037,478 | 6.82% | 0.31% |
| Dec. 8, 2025 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 130000 | $15.08 | 2,948,577.0000 | 64,037,478 | 4.22% | 0.20% |
| Dec. 9, 2025 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 70000 | $14.49 | 2,878,577.0000 | 64,037,478 | 2.37% | 0.11% |
| Feb. 27, 2025 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | A | Class A ordinary shares, par value $0.0001 per share | 95763 | $0.00 | 3,078,577.0000 | 62,870,237 | 3.21% | 0.15% |
| Feb. 29, 2024 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 4740 | $55.89 | 2,982,814.0000 | 49,122,534 | 0.16% | 0.01% |
| Feb. 27, 2024 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 62810 | $55.00 | 3,043,619.0000 | 49,122,534 | 2.02% | 0.13% |
| Feb. 28, 2024 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 56065 | $55.00 | 2,987,554.0000 | 49,122,534 | 1.84% | 0.11% |
| Feb. 21, 2024 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 1125 | $55.27 | 3,106,429.0000 | 49,122,534 | 0.04% | 0.00% |
| Feb. 20, 2024 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 20000 | $57.44 | 3,107,554.0000 | 49,122,534 | 0.64% | 0.04% |
| Feb. 15, 2024 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 20000 | $60.18 | 3,147,554.0000 | 49,122,534 | 0.63% | 0.04% |
| Feb. 16, 2024 | MoonLake Immunotherapeutics | $MLTX | Santos da Silva Jorge | Chief Executive Officer | S | Class A ordinary shares, par value $0.0001 per share | 20000 | $60.15 | 3,127,554.0000 | 49,122,534 | 0.64% | 0.04% |